abemaciclib

#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage
Endpoints
Mon, 09/11/17 - 09:17 am
ESMO
Eli Lilly
Pfizer
Novartis
abemaciclib
breast cancer
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet
Motley Fool
Sun, 07/23/17 - 11:47 am
Biogen
aducanumab
JNJ
apalutamide
Eli Lilly
abemaciclib
AbbVie
Rova-T
Celgene
ozanimod
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Fierce Pharma
Tue, 07/11/17 - 09:56 am
Eli Lilly
Pfizer
Novartis
breast cancer
abemaciclib
Ibrance
Kisqali
ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say
Fierce Pharma
Thu, 05/18/17 - 08:00 pm
ASCO 2017
Eli Lilly
Pfizer
abemaciclib
Ibrance
breast cancer
Eli Lilly says breast cancer combination treatment improved survival rates in late-stage trial
Marketwatch
Mon, 04/24/17 - 10:07 am
Eli Lilly
advanced breast cancer
clinical trials
abemaciclib
Rivals multiplying, Pfizer appeals to doctor preferences with Ibrance's latest label win
Fierce Pharma
Tue, 04/4/17 - 10:58 pm
Pfizer
Ibrance
Novartis
Kisqali
Eli Lilly
abemaciclib
HER-2 negative breast cancer
breast cancer
Phase 3 win moves Lilly's breast cancer drug closer to market
BioPharma Dive
Mon, 03/20/17 - 11:31 pm
Eli Lilly
breast cancer
abemaciclib
Lilly's breast cancer drug combination succeeds key study
Yahoo/Reuters
Mon, 03/20/17 - 10:49 am
Eli Lilly
clinical trials
breast cancer
abemaciclib
Lilly breast cancer drug stumbles, but trial continues
Yahoo/Reuters
Wed, 08/10/16 - 10:03 am
Eli Lilly
clinical trials
breast cancer
FDA
abemaciclib
fulvestrant
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Yahoo
Wed, 07/13/16 - 09:46 am
Eli Lilly
Boehringer Ingelheim
clinical trials
metastatic breast cancer
abemaciclib
BI 836845
Eli Lilly Shows Terrific Innovation
Seeking Alpha
Thu, 06/23/16 - 09:18 am
Eli Lilly
Jardiance
olaratumab
abemaciclib
innovation
diabetes
cancer
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Lilly and Merck pair 'breakthrough' therapies in latest cancer collaboration
Fierce Pharma
Fri, 12/11/15 - 10:46 pm
Eli Lilly
Merck
abemaciclib
Keytruda
oncology
Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer
Yahoo
Thu, 10/8/15 - 09:13 am
Eli Lilly
abemaciclib
advanced breast cancer
FDA
breakthrough therapies